Lanean...
Management of hair loss associated with endocrine therapy in patients with breast cancer: an overview
Endocrine therapy-induced hair loss (ETIHL) associated with aromatase inhibitors and tamoxifen treatment is currently mostly reported but remained an unresolved therapeutic issue in patients with breast cancer (BC) since the number of studies regarding the management is limited in literature. Herein...
Gorde:
| Argitaratua izan da: | Springerplus |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Springer International Publishing
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4864803/ https://ncbi.nlm.nih.gov/pubmed/27247882 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40064-016-2216-3 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|